Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Klf5
REST API REST API
Rattus norvegicus
Klf5 is differentially expressed in 44 experiments: 38 organism parts: hippocampus, frontal cortex, ... (36 more);, 4 disease states: BDL 7 days, Sham, ... (2 more);, 5 cell types 11 compound treatments 2 cellular components and 11 other conditions.
Synonyms IKLF, Bteb2
Orthologs KLF5 (Homo sapiens)   Klf5 (Mus musculus)   klf5a (Danio rerio)   KLF5 (Gallus gallus)   Q4H3A0_CIOIN (Ciona intestinalis)   klf5 (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term angiogenesis, DNA binding, protein binding, regulation of transcription, DNA-dependent, intracellular, transcription, DNA-dependent, positive regulation of cell proliferation, positive regulation of transcription, DNA-dependent, zinc ion binding, microvillus assembly, sequence-specific DNA binding transcription factor activity
InterPro Term Znf_C2H2-like, Znf_C2H2
UniProt Accession Q66HP1, Q9ESF3, F1LSL7
Search EB-eye ENSRNOG00000008785
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-2880, E-GEOD-19830, E-MEXP-1656, E-GEOD-2354, E-GEOD-20388, ... (12 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell type

studied in E-TABM-130

Factor Value U/D Experiments
Sertoli cell
2
1
E-TABM-130
spermatocyte
1
E-TABM-130
1
E-TABM-130
spermatid
1
E-TABM-130
spermatogonium
2
1
E-TABM-130


Disease state

studied in E-MTAB-104, E-MEXP-2583

Factor Value U/D Experiments
Sham
1
1
E-MEXP-2583
bladder carcinoma
1
E-MTAB-104
normal
13
1
E-MTAB-104
BDL 7 days
1
1
E-MEXP-2583


Compound treatment

studied in E-GEOD-6119, E-GEOD-4028, E-GEOD-5282, E-GEOD-22647, E-GEOD-3394 ... (5 experiments)

Factor Value U/D Experiments
pleiotrophin
1
E-GEOD-3394
none
1
E-GEOD-5282
heregulin
1
E-GEOD-3394
glucosamine
1
1
E-GEOD-6119
interleukin 1 beta and glucosamine
1
E-GEOD-6119
AICAR
1
1
E-GEOD-22647
5 more value(s).


Cellular component

studied in E-GEOD-15737

Factor Value U/D Experiments
neuromuscular junction
1
E-GEOD-15737
non-neuromuscular junction
1
E-GEOD-15737


Clinical treatment

studied in E-GEOD-7002, E-MTAB-104

Factor Value U/D Experiments
implanted tumor
1
E-MTAB-104
instillation
1
1
E-GEOD-7002
inhalation
1
1
E-GEOD-7002


Cohort
studied in E-GEOD-20388

Developmental stage
studied in E-GEOD-20245

Fluidics machine
studied in E-TABM-536

Genotype
studied in E-GEOD-20214

Growth condition
studied in E-GEOD-7041

Phenotype
studied in E-MIMR-541

Protocol type
studied in E-MEXP-532, E-MEXP-1565

Strain or line
studied in E-MTAB-322, E-GEOD-4028, E-MTAB-323, E-TABM-45

tissue region
studied in E-GEOD-21681

Treatment
studied in E-GEOD-16981, E-GEOD-19909

Processing time: 0.625 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM